Loading…
Molbio Diagnostics (MOLBIO)₹1,336−1.78%Medical Equipment & Supplies
At the end of the Sep 2026 quarter, Molbio Diagnostics' shareholders were: promoters 41.24%, FIIs 1.52%, DIIs 16.39%, government 0.02%, public 40.83%. 0.00% of promoter shares were pledged. It had 2,33,617 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2026 | |
|---|---|
| Promoters | 41.24% |
| FIIs | 1.52% |
| DIIs | 16.39% |
| Government | 0.02% |
| Public | 40.83% |
| Promoter shares pledged | 0.00% |
| Number of shareholders | 2,33,617 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Exxora Trading Llp | Promoter | 37.00% | — |
| Business Excellence Trust Iii - India Business Exc | DII | 11.47% | — |
| V-Sciences Investments Pte Ltd | Public | 8.75% | — |
| Gopalkrishna Mangalore Kini | Public | 5.60% | — |
| Gopalakrishna Sampathgiri | Public | 4.55% | — |
| Javagal Guru Dutt | Public | 4.49% | — |
| Chandrasekhar Bhaskaran Nair | Promoter | 4.28% | — |
| Usha Rani M A | Public | 2.43% | — |
| Sangeetha Mangalore Kini | Public | 2.27% | — |
| Rohit Mullangi Ashok Kumar | Public | 1.46% | — |
| Shruthi G Kini | Public | 1.10% | — |
Promoters held 41.24% of Molbio Diagnostics at the end of the Sep 2026 quarter.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 1.52% and domestic institutions (DIIs) held 16.39%.
No. The Sep 2026 filing shows no pledged promoter shares.
Molbio Diagnostics had 2,33,617 shareholders at the end of the Sep 2026 quarter.
Business Excellence Trust Iii - India Business Exc (DII) held 11.47% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.